Data gathered: October 22
Alternative Data for hims
About hims
Hims & Hers Health, Inc. is a telemedicine company that operates Hims and Hers, which sell men's and women's personal care products. Hims, Inc. was founded in 2017 with the launch of Hims, and Hers was launched in 2018. In January 2019, Hims became the second-fastest startup to become a so-called 'unicorn' after Bird.
| Price | $46.65 |
| Target Price | Sign up |
| Volume | 15,240,000 |
| Market Cap | $11.3B |
| Year Range | $25.35 - $68.74 |
| Dividend Yield | 0% |
| PE Ratio | 65.01 |
| Analyst Rating | 43% buy |
| Earnings Date | November 3 '25 |
| Industry | Retail |
In the news
 |
HIMS Stock Declines Despite Launch of New Specialty in Women's HealthOctober 21 - Yahoo |
Keybanc Initiates Coverage of Hims & Hers Health (HIMS) with Sector Weight RecommendationOctober 20 - Fintel |
|
|
Hims & Hers Health (HIMS) Stock Is Up, What You Need To KnowOctober 20 - Yahoo |
|
Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth ExpectationsOctober 17 - Yahoo |
|
OMCL or HIMS: Which Is the Better Value Stock Right Now?October 17 - Yahoo |
|
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader MarketOctober 16 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 545M | 129M | 416M | 43M | 37M | 0.170 |
| Q1 '25 | 586M | 155M | 431M | 49M | 66M | 0.200 |
| Q4 '24 | 481M | 112M | 370M | 26M | 25M | 0.110 |
| Q3 '24 | 402M | 84M | 318M | 76M | 27M | 0.320 |
| Q2 '24 | 316M | 59M | 257M | 13M | 15M | 0.060 |
Insider Transactions View All
| Okupe Oluyemi filed to sell 70,232 shares at $57.1. October 20 '25 |
| Dudum Andrew filed to sell 109,190 shares at $63.4. October 20 '25 |
| Dudum Andrew filed to sell 92,523 shares at $62.7. October 20 '25 |
| Dudum Andrew filed to sell 47,524 shares at $63.5. October 20 '25 |
| Dudum Andrew filed to sell 150,857 shares at $63.5. October 20 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
CostcoCOST |
$949.4 1.3% | 44 |
 |
Dollar TreeDLTR |
$101.07 2.1% | 40 |
 |
TargetTGT |
$94.23 0.2% | 31 |
 |
Macy'sM |
$18.53 1.6% | 39 |
 |
Best BuyBBY |
$81.84 1% | 41 |
Read more about hims (HIMS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, tiktok followers, twitter followers, twitter mentions, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of hims?
The Market Cap of hims is $11.3B.
What is hims' PE Ratio?
As of today, hims' PE (Price to Earnings) ratio is 65.01.
When does hims report earnings?
hims will report its next earnings on November 3 '25.
What is the current stock price of hims?
Currently, the price of one share of hims stock is $46.65.
How can I analyze the HIMS stock price chart for investment decisions?
The HIMS stock price chart above provides a comprehensive visual representation of hims' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling hims shares. Our platform offers an up-to-date HIMS stock price chart, along with technical data analysis and alternative data insights.
Does HIMS offer dividends to its shareholders?
As of our latest update, hims (HIMS) does not offer dividends to its shareholders. Investors interested in hims should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of hims?
Some of the similar stocks of hims are Costco, Dollar Tree, Target, Macy's, and Best Buy.
.
